NIH-funded research R01 grant

Understanding the causes of SPG4 Hereditary Spastic Paraplegia

Official title: Mechanisms of SPG4 Hereditary Spastic Paraplegia

Funded at Drexel University · NIH-10892167 · Data updated 2026-11-12

This study is looking into how changes in the SPAST gene cause problems in the nerves for people with SPG4 Hereditary Spastic Paraplegia, with the hope of finding new ways to help those affected by this condition.

More Hereditary Spastic Paraplegia research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDrexel University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 30, 2020
Project endJune 30, 2025
Funding year2024
Award (this year)$621,750
NIH project number5R01NS118177-05
Project IDNIH-10892167 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with SPG4 Hereditary Spastic Paraplegia, particularly those with known mutations in the SPAST gene.

Less likely to help

Patients with other forms of hereditary spastic paraplegia or unrelated neurological disorders may not benefit from this research.

What this research studies

This research investigates the mechanisms behind SPG4 Hereditary Spastic Paraplegia, a genetic condition that leads to progressive weakness and stiffness in the limbs due to degeneration of specific nerve pathways. The study focuses on the role of the SPAST gene and its protein, spastin, in the disease process. Researchers aim to uncover how mutations in this gene contribute to nerve damage and explore potential toxic effects of mutant proteins. By examining these mechanisms, the research seeks to provide insights that could lead to new treatment strategies for affected individuals.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and potential therapies for patients suffering from SPG4 Hereditary Spastic Paraplegia.

How similar studies have gone: Previous research has shown promise in understanding similar neurodegenerative conditions, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Drexel University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Baas, Peter W. — Drexel University
  • Study coordinator: Baas, Peter W.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.